Loading...
Loading...
Browse all stories on DeepNewz
VisitNature Study Links RNU4-2 Variants to 0.4% of Neurodevelopmental Disorders
Jul 12, 2024, 01:08 AM
A groundbreaking study published in Nature has identified de novo variants in the RNU4-2 snRNA as a frequent cause of neurodevelopmental disorders (NDD). The research highlights that mutations in the RNU4-2 gene, a non-coding gene encoding a small nuclear RNA (snRNA), are linked to a significant number of NDD cases, explaining up to 0.4% of these disorders. Notably, the de novo variants, which involve a stretch of 18 bp, were all found on the maternal allele. This discovery marks a landmark moment in the history of NDD genetics, with hundreds of individuals already diagnosed with severe developmental delays due to these mutations.
View original story
Markets
No • 50%
Yes • 50%
ClinicalTrials.gov or relevant clinical trial registry
Yes • 50%
No • 50%
Publication in a peer-reviewed journal
No • 50%
Yes • 50%
FDA official announcements and approval databases
Less than 500 • 25%
More than 1500 • 25%
1001-1500 • 25%
500-1000 • 25%
Genetic research publications or health organization reports
RNU4-3 • 25%
Other • 25%
RNU4-1 • 25%
RNU4-4 • 25%
Publication in a peer-reviewed journal or genetic databases
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Press releases from pharmaceutical companies or major news outlets